| 000 | 01728 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513083416.0 | ||
| 264 | 0 | _c19960201 | |
| 008 | 199602s 0 0 eng d | ||
| 022 | _a0891-5849 | ||
| 024 | 7 |
_a10.1016/0891-5849(95)00062-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOllinger, K | |
| 245 | 0 | 0 |
_aCellular injury induced by oxidative stress is mediated through lysosomal damage. _h[electronic resource] |
| 260 |
_bFree radical biology & medicine _cNov 1995 |
||
| 300 |
_a565-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytochalasin B _xpharmacology |
| 650 | 0 | 4 |
_aCytosol _xmetabolism |
| 650 | 0 | 4 |
_aDeferoxamine _xpharmacology |
| 650 | 0 | 4 |
_aEndocytosis _xdrug effects |
| 650 | 0 | 4 |
_aGlutathione _xmetabolism |
| 650 | 0 | 4 |
_aIron Chelating Agents _xpharmacology |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLysosomes _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMonensin _xpharmacology |
| 650 | 0 | 4 |
_aNaphthoquinones _xantagonists & inhibitors |
| 650 | 0 | 4 | _aOxidative Stress |
| 650 | 0 | 4 |
_aPhenylenediamines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBrunk, U T | |
| 773 | 0 |
_tFree radical biology & medicine _gvol. 19 _gno. 5 _gp. 565-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0891-5849(95)00062-3 _zAvailable from publisher's website |
| 999 |
_c8529021 _d8529021 |
||